← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 4,416

Funds Holding Change -91

Funds Holding Growth -2%

Value $909B

Holding in Top 10 558

Top 10 Change -188

Top 10 Growth -25%

Value Growth -4%

New 193

Increased 1,928

Reduced 1,970

Closed 189

Capital Inflow $40.5B

Capital Outflow $27.4B

Net Capital Flow +$13.1B

Capital Flow Change +$8.97B

Calls $10.4B

Puts $9.77B

Net Calls +$660M

Put/Call Ratio 0.94